Syprine

This page contains recent news articles, when available, and an overview of Syprine but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Aton Pharma Strikes Deal with Brazilian Distributor  -  May 12, 2008
Syprine, which is given to Wilson''s disease patients who cannot tolerate ... Cuprimine is approved in Brazil but Meizler is working to get Syprine approved ... NJBIZ

Press Release: Aton Pharma Announces Distribution Partnership in...  -  May 12, 2008
..."Cuprimine and Syprine are medically essential products, and Aton is committed to making these products available wherever they are needed," said Michael G. ... Pay-Per-View - PR Newswire - HighBeam Research

Pipex Completes Reverse Merger, Reports Positive Coprexa Data  -  Nov 9, 2006
In the pivotal trial, patients were treated first with either Syprine (trientine, ... Those given Syprine showed a 26 percent incidence (6 of 23) of ... BioWorld Online - BioWorld Online

Iron.  -  May 1, 2006
Trientine (Syprine(R)) * Dairy products, eggs * Gossypol * Soy * Zinc, Vanadium Warnings: ... Product Information: Syprine(R), trientine hydrochloride. ... Free with registration - AltCareDex Alternative Medicines - AccessMyLibrary.com

Wilson's Disease - Symptoms, Diagnosis, Treatment of Wilson's Disease...  -  Aug 7, 2008
Trientine (Syprine) binds (chelates) the copper increases its release through the urine. Zinc acetate (Galzin) blocks copper from being absorbed in the ... New York Times

Wilson's disease  -  Oct 28, 2008
Trientine (Syprine). Another chelating agent, trientine also binds to copper and helps eliminate it from your body. Because it's less toxic than ... CNN

الهندباء البرية تحمي الكبد من التليÙ? وتقي من مرض ويلسون  -  Feb 14, 2005
هذه الحالة دواء ترنتين سايبرين Trientine syprine كبديل، حيث انه يقوم باستخلاص النحاس أيضاً ... الرياض

Pipex Therapeutics' COPREXA Pivotal Clinical Trial Results Presented...  -  Nov 7, 2006
In this double-blind, randomized, comparator, pivotal clinical trial, 48 Wilson's disease patients were initially treated with either trientine (Syprine(r)) ... primezone.com

Loislaw Federal District Court Opinions - AMERICAN HOME ASSUR. CO. …  -  Sep 9, 2005
...[fn4] American Home asserts that Merck also seeks coverage for a diluent and for capsules of syprine, another Merck-manufactured drug, that were shipped ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

AGA releases position statement on gastrointestinal medication use …  -  Mar 1, 2007
...have the dosage reduced to 250 mg per day by the third trimester; trientine (Syprine) appears to be a more low-risk option for managing this disease. ... $4.95 - American Family Physician - ECNext

Company Profile Report  -  Apr 5, 2008
Cuprimine (Penicillamine); Syprine (Trientine Hydrochloride). Phase I/Phase II Clinical Stage Products. Products:. MK-0608 ... $50.00 - Revere Reports - Revere

لها أون لاين - موقع المرأة العربية  -  Jun 21, 2006
Cuprimine والمضاعÙ?ات هذه الأدوية مثل \r\nTrientine syprine\r\nلكن من مشاكل هذه الأدوية النقص ... lahaonline.com





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy